Our mission is to provide new products and services to society that mean a breakthrough in the prevention and personalized treatment of different pathologies
Biomeb is a health technology company promoting metabolomics for precision medicine as well as research in other fields of life science, providing new products and services to society that means a breakthrough in the prevention, diagnosis and personalized treatment of different pathologies.
Our metabolomics approach is a competent technology for assessing one’s metabolic state that can be used to hand in tips to achieve a healthier lifestyle.
Currently we collaborate on different research projects together with entities and professionals for the development of new products and services.
Multifunctional Dietary fibre to tackle metabolic syndrome. Fibracep® is a new patented bioactive product based on fibres extracted from natural sources, clinically tested.
In several aleatorized, placebo-controlled clinical trials, Fibracep® is effective to modulate the risk of metabolic syndrome development, by acting on several of its components.
Well B is conceived as an emerging approach for disease prevention and lifestyle management that considers each person as a whole using metabolomics, anthropometric, biochemical, environmental and lifestyle data to assess cardiovascular health in a personalized manner.
Thus, Well B provides precise personal nutritional recommendations based on the metabolic profile for improved health through personalized nutrition.
Our commitment to research, development and Innovation, provided by a high level scientific and management team with years of experience, has given rise to a portfolio of new projects that will guarantee the release to the market of new products and services in the short/medium term.
Biomeb offers basic equipment from our biomedical laboratory, as well as high-performance equipment such as different chromatographs (liquid and gases) coupled to mass spectrometers (QTOF, TQD). This equipment has allowed the development of innovative technologies such as metabolomics that has been applied to the health field.
Biomeb’s scientific team is part of the NUTREN research group from the University of Lleida and the Biomedical Research Institute of Lleida (IRBLLEIDA). It has more than 200 publications of international impact in the areas of development of our products.
Biomeb’s R&D&I strategy for the upcoming years will be our investment in the development of new products and services using metabolomics applied to the health and agri-food sectors and the design and development of new foods together with the discovery of new biomarkers.
Metabolomics at your service
We offer a complete metabolomics service in the following areas
Support the discovery, development and validation of biomarkers.
Discovery and development of customizable bioactive therapeutic targets and compounds.
Advancing knowledge and discovery of new biomarkers.
Characterization of bioactive compounds and bioavailability.
Elias Daura (PhD, MBA)
Degree in Chemistry from the Rovira i Virgili University (URV) and a PhD from the URV. Master of Business Administration (MBA) from the Rovira i Virgili University Foundation (FURV), Tarragona.
His CV stands out for its strong background and experience in R+D+I management. He has developed his career as head of project management in a research centre and as a managing director in another centre related to biomedical research.
Founder, Scientific Director
Manuel Portero-Otín (MD, PhD)
PhD in Medicine and Surgery from the University of Lleida in 1997. Manuel specializes in Somatic Aging Endocrine Physiology and Pathophysiology after several postdoctoral stays at CWRU (Cleveland, OH, USA) U Essex (Colchester, UK), INSERM (Toulouse, France), with the help of organizations such as EMBO, FEBS and EASD.
He has been Chief Deputy Dean of Studies during 7 years, Associate Professor and co-director of NUTREN-nutrigenomics technology center. He has more than 130 international publications and he has participated in 50 projects in basic and applied research. He is reviewer of several publications, as J Biol Chem, Carbohydrate Res, Diabetologia, Biochimie, and has participated in evaluation of projects in various national and international agencies.
Founder, Managing Partner
Heily Ferrer (Eng., MBA)
Technical Telecommunications Engineer from the Rovira i Virgili University (URV) and Master of Business Administration (MBA) from the Rovira i Virgili University Foundation (FURV), Tarragona.
He has extensive experience in both technological and engineering project management, a field in which he has dedicated most of his career, and in the comprehensive management for funding and tax incentives for R&D and innovation.
Mariona Jové (PhD)
Degree in biology and biochemistry and a PhD from the University of Lleida in 2010 (Metabolic Pathophysiology Group, Department of Experimental Medicine).
She specializes in Physiology, chromatographic analysis and mass spectrometry, with reference to nutritional metabolomics by a premier industry reference (Agilent Technologies). She accredits more than 30 national and international publications, most in the first quartile of impact with international stays at INSERM (Toulouse, France) and Glasgow University (Glasgow, UK), having participated in various projects in basic and applied research, with broad multidisciplinary.
Founder, Technical Manager
Èlia Obis (PhD)
Degree in Biological Sciences from the University of Barcelona and a PhD from the University of Lleida.
She specializes in biochemistry, proteomics, metabolism and oxidative stress. Moreover, she accredits various publications and presentations at international conferences, having participated in various projects at National and European level. She has additional training in business innovation through the Executive Master in Innovation at the EOI (Madrid).
Member of the Board of Directors
Ferran Iturbe (PDG, MBA)
Diploma in Business Studies from the University of Lleida, Master of Business Administration (MBA (MBA) from ESADE and General Management Program (PDG) from IESE.
He is currently Managing Director of Teyme and Managing Director of Globalleida Inversions. He has an extensive experience in business management with more than 18 years of experience in executive positions.
Researcher & data analyst
Alberto Pasamontes (PhD)
Gegree in Chemistry and Biochemistry from the Rovira i Virgili University (URV) in Tarragona and a PhD in Analytical Chemistry from the URV.
He specializes in Chemometrics and Qualimetrics applied in biochemistry data. After several postdoctoral stays in industry at Dow Chemical and Shirota Functional Foods and in academia at UC Davis (USA) and Leiden University (NL), he developed his professional career in Metabolomics and Chemometrics.
Anna Fernández (PhD student)
Degree in Biochemistry from the University of Barcelona (UB) and Master of Neuropsychology from UOC (Barcelona). She also has a postgraduate degree in Quality Systems in Industry and Pharmaceutical Research from the University of Barcelona (UB).
The training in chromatographic analysis and mass spectrometry received at the Biomedical Research Institute of Lleida (Metabolic Physiopathology Research Group) stands out among her research training. Currently, she is a PhD student in our company.